Aikens, Kimberly A. MD, MBA; Astin, John PhD; Pelletier, Kenneth R. PhD, MD (hc); Levanovich, Kristin MS; Baase, Catherine M. MD; Park, Yeo Yung PhD; Bodnar, Catherine M. MD, MPH
From the The Aikens Approach, LLC (Dr Aikens), Ann Arbor, Michigan; California Pacific Medical Center (Dr Astin), San Francisco; University of Arizona School of Medicine and University of California School of Medicine (Dr Pelletier), San Francisco; The Dow Chemical Company (Dr Baase), Midland; Department of Internal Medicine, Cardiology (Dr Park), University of Michigan, Ann Arbor; and The Dow Chemical Company (Dr Bodnar), Midland, Michigan.
Address correspondence to: Kimberly A. Aikens, MD, MBA, The Aikens Approach, LLC, 3955 Hanover Circle, Loxahatchee, FL 33470 ([email protected]).
All funding was provided by the American Health Association.
Dr Kimberly Aikens is the founder of The Aikens Approach LLC and the program developer. Nevertheless, she received no remuneration of any type for this research project or the work done at The Dow Chemical Company. Other authors declare no conflicts of interest.
doi: 10.1097/JOM.0000000000000209
